You can read our Premium News Service in full if you have an Annual Subscription to the OTCToolbox website. You can read Basic News stories free of charge.
14 April 2022
Reckitt has announced that it plans to transfer the ownership of its Russian business in light of the ongoing war in Ukraine.
6 April 2022
Sweden's Karo Pharma has completed the acquisition of E45 from Reckitt, Brazil's Hypera Pharma has completed deals with Sanofi and Eurofarma, and Ireland-based Perrigo has launched a USD500 million private offering.
28 March 2022
India’s Emami is boosting its personal and healthcare business in its home market by acquiring the Dermicool brand from Reckitt for INR4.32 billion (USD57 million) excluding taxes and duties.
24 March 2022
Reckitt has relaunched Queen V in the US and is planning a global rollout for the recently-acquired feminine sexual wellness brand.
21 February 2022
Reckitt is moving its vitamins, minerals and supplements (VMS) business out of its Nutrition division and into its Health division.
24 December 2021
Sweden’s Karo Pharma is set to acquire the E45 dermatology brand from Reckitt in a deal worth GBP200 million (USD268 million).
17 December 2021
Reckitt and Recordati have announced people appointments.
2 November 2021
Reckitt has extended its Mucinex cough and cold brand in the US with a line of products to “help sore throat sufferers power through without the pain”.
2 November 2021
Medlab Clinical has sold its Australian nutraceuticals business to PharmaCare and Reckitt has sold its stake in Mead Johnson Nutrition Argentina.
19 August 2021
Reckitt’s Nuromol has become the first combination medicine containing ibuprofen and paracetamol to be allowed on general sale outside pharmacies in the UK. The company has been awarded one year of data exclusivity for studies carried out to support the switch from pharmacy (P) to general-sale list...